Single-dose Ad26.COV2.S vaccine provides moderate protection against Covid-19 related outcomes
1. One dose of Ad26.COV2.S (Johnson & Johnson) provided some protection against moderate to severe Covid-19-related infection and medical intervention....
BNT162b2 safe and efficacious in children 5 to 11 years of age
1. A two-dose regimen of BNT162b2 at 10μg elicits a sufficient immune response in children 5 – 11 years of...
Fourth BNT162b2 vaccine dose provides short-term effectiveness against Covid-19 related outcomes
1. Patients receiving the fourth dose of BNT162b2 (Pfizer-BioNTech) showed reduced rates of symptomatic Covid-19 infection and hospitalization compared to...
Respiratory syncytial virus (RSV) vaccine produces transplacental neutralizing antibodies in pregnant women
1. The prefusion F protein of RSV (RSVpreF) vaccine produces neutralizing antibodies against RSV in both the serum of the...
Covid-19 vaccines and boosters are transiently effective against the Omicron
1. Two doses of BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) vaccine provided good protection against the Omicron (B.1.1.529) variant but rapidly...
An implantable system overcomes orthostatic hypotension in a patient with multiple-system atrophy
1. In this case report, a patient with multiple-system atrophy was alleviated from orthostatic hypotension symptoms upon installation of an...
Neoadjuvant nivolumab improves survival in patients with resectable non-small cell lung cancer
1. Patients with resectable non-small cell lung cancer (NSCLC) receiving neoadjuvant nivolumab in addition to platinum-based chemotherapy demonstrated longer survival...
Protection against SARS-CoV-2 highest after infection-acquired immunity boosted with vaccination in health care workers
1. SARS-CoV-2 infection-acquired immunity waned after 1 year, but immune protection remained high beyond 1 year in those boosted with...
BNT162b2 vaccination after SARS-CoV-2 infection decreases risk of recurrent infection
1. In a retrospective cohort study of individuals who recovered from SARS-CoV-2, BNT162b2 vaccination decreased the risk of recurrent infection....
Darolutamide improves overall survival in patients with hormone-sensitive prostate cancer
1. Patients with hormone-sensitive prostate cancer receiving darolutamide, an androgen-receptor inhibitor, in addition to standard therapy demonstrated longer overall survival...